14 years of experience with neural prosthetic systems at Stanford and the University of Michigan.
- University of Michigan
- Ann Arbor, MI
The following is a list of all speakers for the NANS 23rd Annual Meeting.
14 years of experience with neural prosthetic systems at Stanford and the University of Michigan.
Lauren Cimino, MSN APRN AGPCNP-BC, is a nurse practitioner working at Northwestern Medicine in Chicago, IL. She completed her BSN from Illinois State University and her MSN from University of Illinois Chicago. She has been apart of Northwestern's neurosurgery department for six years working specifically in functional neurosurgery as an outpatient nurse practitioner. She has been a registered nurse for twelve years with a background treating patients with neurological diseases. Lauren has been apart of the NANS APP faculty for three years and enjoys mentoring APPs that are new to neuromodulation and neurosurgery.
Dr. Clark is a neurosurgery attending at Sentara Neurosurgical Specialists.
Dr. Luana Colloca is an NIH-funded associate professor at the University of Maryland and an honorary professor at the University of Sydney School of Psychology. Dr. Colloca holds an MD, a master degree in bioethics and a PhD in neuroscience and completed a post-doc training at the Karolinska Institute in Stockholm, Sweden and a senior research fellowship at the National Institutes of Health in Bethesda, MD. Over the last 17 years, Dr. Colloca has conducted pioneering ground-breaking studies that have an advanced scientific understanding of the psychoneurobiological bases of endogenous systems for pain modulation in humans including the discovery that the vasopressin system is involved in the enhancement of placebo effects with a dimorphic effect. As a result, Dr. Colloca has developed an international reputation as a leading scientist for advancing knowledge of the neurobiological mechanisms of placebo and nocebo effects with an integrative approach including psychopharmacological, neurobiological and behavioral approaches. Her research has been published in top-ranked international journals including Biological Psychiatry, Pain, JAMA, and Lancet Neurology. Her research has been also featured on The National Geographic, The New Scientist, Washington Post, Science daily, Boston Globe, The New Yorker, Nature, The Guardian, The Wall Street Journal, News and World Reports and USA Today. Dr. Colloca has been recently honored with prestigious awards including the 2016 Wall Patrick International Award for basic research on pain mechanisms by the International Association for Study of Pain (IASP).
Arthur Cukiert was born in Santo Andre, Brazil in July 23rd, 1963. He graduated at Sao Paulo University in 1986 and finished his neurosurgical training at the Hospital das Clinicas of Sao Paulo University in 1991. He spent a year at the Montreal Neurologic Institute as a clinical and research fellow. Back in Brazil, he worked at Sao Paulo Hospital das Clinicas, developed the Hospital Brigadeiro neurosurgical service and was a medical assistant at the ABC Faculty of Medicine in Sao Paulo. He received a PhD degree in neurophysiology in 1996 from the Biological Sciences Institute of the Sao Paulo University. He is presently the director of the Sao Paulo Epilepsy Clinic, and head of its Epilepsy Surgery Program. He is part of the ILAE Pediatric Surgery Task Force and had organized several Epilepsy Surgery Techniques Meetings over the years. He was president of the Brazilian Functional Neurosurgery Society and of the Brazilian Congress of Update in Neurosurgery. He presented more than 400 lectures worldwide, attended to 350 meetings, presented 800 abstracts and published 150 peer-reviewed papers and 8 books. His activities center on the surgical treatment of refractory epilepsy and pituitary tumors.
Scientist, leader, and entrepreneur in the field of bioelectronic medicine for 20 years, with particular emphasis on neuromodulation to control inflammation and hemostasis.
Tenured Professor of Anesthesiology of the School of Medicine. Department Surgical Specialties. University of Valencia, Spain. Chairman of Anesthesia, Critical Care and the Multidisciplinary Pain Management Departments in the Valencia University General Hospital (Valencia, Spain). European Society of Regional Anesthesia and Pain Therapy (ESRA): Past-President, Chairman of the scientific committee in the board of directors. Vice-Chairman in the board of European Diploma of Pain Medicine (EDPM). International Neuromodulation Society Member of the Society Liaison and Advocacy committee. Publications: Articles in Peer reviewed journals 178 Articles in international journals and 187 Articles in national journals, with Accumulated impact factor: 271.854, and Index H of Hirsch: 24. Contributed in the area of pain management and neuromodulation with 30 books, and 203 Chapters and collaborations in national and international books of the specialty. Editorial Board Journals: Reviewer on editorial boards of international and national journals in the field of Regional Anaesthesia and Pain Medicine. Associate editor in the Journal "Regional Anesthesia and Pain Medicine." Editor of "Pain Practice." Associate Editor of "The Clinical Journal of Pain." Associate Editor of "European Journal of Pain-Supplementss." Associate Editor of "Neuromodulation: Technology at the Neural Interface." Scientific board member of Journal 'Fighting Pain.' Guest Reviewer in several international journals. Education: Multiple teaching duties, including Lecturer in courses and hands on demonstrations. Examiner in the exams of the European Diploma of Anaesthesia and Intensive Care (EDAIC) of European Society of Anaesthesia (ESA); European Diploma of Pain Medicine (EDPM) of European Society of Regional Anesthesia and Pain Therapy (ESRA); European Diploma of Regional Anaesthesia (EDRA) and European Diploma of Pain Medicine (EDPM) of European Society of Regional Anesthesia and Pain Therapy (ESRA), and Fellow of Interventional Pain Practice (FIPP) of World Institute of Pain (WIP).
Dr. Oscar de Leon-Casasola is the senior vice-chair, and professor of anesthesiology (Tenure Track) in the department of anesthesiology, and professor of medicine at the University at Buffalo, School of Medicine and Biomedical Sciences. He also is chief of the division of pain medicine and professor of oncology at Roswell Park Cancer Institute, Buffalo, NY. Dr. de Leon-Casasola received his medical training at the Universidad de San Carlos de Guatemala after obtaining a degree in music with a specialty in piano. He then underwent surgical residency SUNY at Downstate, followed by anesthesia residency at SUNY-Buffalo. He is board certified in anesthesiology, critical care medicine, and pain management. He has served as director of the Acute Pain Service, director of the Surgical Intensive Care Unit, and chief of critical care medicine at Roswell Park Cancer Institute. He has received many honors and awards and has served as visiting professor at several Universities in the U.S., Latin-America, and Europe. Dr. de Leon-Casasola has lectured at more that 150 academic institutions and hospitals throughout North and South America, and Europe. He has authored or co-authored more than 100 papers in major scientific journals and has been a chapter contributor in many books. He has published the books Cancer Pain - Pharmacological, Interventional, and Palliative Care Approaches (Elsevier) and the book Acute Pain Management (Cambridge University Press), and Interventional Techniques for the Treatment of Chronic Pain (Glosa).
Dr. de Leon-Casasola is a member of the board of directors of the American Society of Regional Anesthesia and Pain Management (ASRA) where he currently serves as president and has served as the chair of the scientific committee for that Society's pain meeting. He is also a member of the pain medicine committee of the American Society of Anesthesiologist (ASA) and the National Comprehensive Cancer Network, Adult Cancer Pain Panel. He served as the chair of the regional anesthesia committee of the ASA until 2010. He served as a member in the Task Force of the ASA that created the Society's Guidelines for the treatment of Chronic Pain Management that were published in 2010 and currently serves as the co-chair of the committee drafting the Acute Pain Guidelines for the ASA and the American Pain Society. Dr. de Leon-Casasola has been honored with many awards; the most recent ones include "Top Doctors in the US," "Best Doctors in the US," and "100 Top Docs in Buffalo" for the last 15 years.
Christine Ann Denny, PhD, is an associate professor of clinical neurobiology in psychiatry at Columbia University and a research scientist V in the Division of Systems Neuroscience at the New York State Psychiatric Institute. She received a BS from Boston College in 2005, an MS from Boston College in 2006, and her PhD in biological sciences from Columbia University in 2012, where she investigated the impact of adult hippocampal neurogenesis on behavior in the laboratory of Dr. René Hen. After receiving the NIH DP5 Early Independence Award, she started her own laboratory in 2013 at Columbia University. Dr. Denny studies the neural basis of learning and memory in disease states, such as in depression and Alzheimer's disease (AD). Specifically, she created an activity-dependent tagging murine line, the ArcCreERT2 mice, which allows for the permanent labeling of individual memories. In addition, Dr. Denny's laboratory is developing small molecule compounds to protect against stress.
Mehul J. Desai, MD MPH, is board certified in pain medicine and physical medicine and rehabilitation. During residency he spent 6 months completing a research fellowship at the National Institutes of Health conducting groundbreaking research into mechanisms of muscle pain. His clinical interests include musculoskeletal disease (tendon injuries, osteoarthritis), discogenic pain and intradiscal therapies including biologics, neuromodulation; specifically, spinal cord stimulation and targeted drug delivery, complex spinal conditions, pelvic pain, outcomes-based research and healthcare economics. Dr. Desai is the founder and medical director of the International Spine, Pain & Performance Center, a collaborative, interdisciplinary practice located in Washington, DC.
Formerly, Dr. Desai was assistant professor at the department of anesthesiology and critical care medicine and of neurosurgery at the George Washington University Medical Center and served as the director of pain medicine and non-operative spine services of the GW Spine & Pain Center, director of the Outpatient Rehabilitation Center at the George Washington University Hospital, and director of the Sibley Pain Center at the Sibley Memorial Hospital. Dr. Desai maintains an avid interest in research, serving as the principle investigator on multiple ongoing clinical trials including studies on radiofrequency ablation and spinal cord stimulation. Dr. Desai has published articles in Pain Practice, Neuromodulation, Pain Physician, Archives of Physical Medicine and Rehabilitation, and Pain Medicine. He has authored multiple book chapters and is currently completed his second textbook. Dr. Desai currently served as a leadership fellow for the American Academy of Physical Medicine & Rehabilitation and the 2016 Legislative Fellow for the North American Neuromodulation Society.
Teresita DeVera is a nurse practitioner in the department of neurosurgery at Jefferson University Hospital. She has 19 years of experience in both spinal and functional neurosurgery, starting as a nurse in the ICU setting, now working as a nurse practitioner directly under the guidance of Dr. Ashwini Sharan and Dr. Chengyuan Wu. She collaborates with her physicians, managing and educating patients with chronic pain, epilepsy, and movement disorders. One of her goals as a nurse practitioner is to improve patient outcomes by increasing APP involvement and bridging the gap in communication between treating physicians.
Dr. Durphy is a fellowship-trained movement disorders specialist. She completed her medical school training at Indiana University in 2007 and went on to complete a neurology residency at Georgetown University in 2011. In 2012 she completed a fellowship in movement disorders at Albany Medical Center, where she has stayed on as assistant professor of neurology. Her practice is composed of patients diagnosed with conditions including Parkinson's Disease, essential tremor, Huntington's Disease and dystonia. She has a special interest in intraoperative monitoring of deep brain stimulation surgery as well as post-operative deep brain stimulation management.
Jacek is an assistant professor in the department of biomedical engineering at the City College of New York. He received his PhD in telecommunications from the Institut National de la Recherche Scientifique (Montreal, Canada) in 2008, and was awarded the Canadian Governor General's Academic Gold Medal. Previously to joining the faculty at CCNY, he was a research associate in the lab of Anthony Norcia at Stanford University (2013-2015), and a postdoctoral fellow in the lab of Lucas Parra at the City College of New York (2008-2013).
Bo Duan, PhD, is an assistant professor at the University of Michigan. Dr. Duan received a bachelor's degree in polymer chemistry at the University of Sciences and Technology of China in 2002. He earned his PhD degree in neuroscience at the Institute of Neuroscience, Chinese Academy of Sciences in 2007 and worked there until 2010. He did his postdoctoral work at Harvard Medical School from 2010-2016. Dr. Duan joined the faculty at the University of Michigan as an assistant professor in 2016. The Duan lab uses a combination of mouse genetics, histochemistry, neuroanatomical tracing, electrophysiology, in vivo imaging, and behavior analyses to gain understanding of the development, organization, and function of neural circuits that underlie a variety of somatosensory modalities, such as temperature, touch, pain, and itch.
Rui Duarte is deputy director and health technology assessment lead at the Liverpool Reviews and Implementation Group (LRiG), University of Liverpool, United Kingdom. He is an experienced health economist and systematic reviewer with multiple publications in the field of neuromodulation since 2010. He is the health economics co-applicant on a number of UK National Institute for Health Research (NIHR) clinical trials investigating the effectiveness and cost-effectiveness of spinal cord stimulation.
Robert H. Dworkin received his BA from the University of Pennsylvania and his PhD from Harvard University. He is a professor of anesthesiology and perioperative medicine, neurology, and psychiatry and professor in the Center for Health and Technology at the University of Rochester School of Medicine and Dentistry. Dr. Dworkin is also director of the analgesic, anesthetic, and addiction clinical trial translations, innovations, opportunities, and networks (ACTTION) public-private partnership with the U.S. Food and Drug Administration (FDA) and a special government employee of the FDA Center for Drug Evaluation and Research; he previously served as a consultant to and member of the FDA Anesthetic and Life Support Drugs Advisory Committee and as a member of the U.S. Centers for Disease Control and Prevention Herpes Zoster Working Group.
He is an associate editor of Pain and a member of the editorial boards of Canadian Journal of Pain and Journal of Pain. Dr. Dworkin received the American Pain Society’s Wilbert E. Fordyce Clinical Investigator Award in 2005 and John and Emma Bonica Public Service Award in 2014, the Eastern Pain Association’s John J. Bonica Award in 2011, Raymond Houde Lectureship Award in 2018, the American Academy of Neurology’s Mitchell B. Max Award for Neuropathic Pain in 2015, and the American Academy of Pain Medicine’s Founders Award in 2018. He has authored over 300 journal articles and book chapters, which have been cited over 36,000 times (h index = 87).
Dr. Dworkin’s major research interests are methodologic aspects of analgesic clinical trials and treatment and prevention of chronic and acute neuropathic and musculoskeletal pain. The primary focus of his current research involves the identification of factors that increase the assay sensitivity of clinical trials to detect differences between an active and a placebo control or comparison treatment. In ongoing studies, he and his colleagues are examining the relationships between clinical trial results and their research designs, patient characteristics, statistical methods, and outcome measures. Dr. Dworkin has also been very interested in the identification of risk factors for the transition from acute to chronic pain. One of the major results of this program of research has been that patients with greater acute pain are more likely to develop chronic pain. This suggests that attenuating acute pain might prevent chronic pain, and an additional focus of his research has involved developing approaches to test this hypothesis.
Sam Eldabe is a consultant in anaesthesia and pain medicine at the James Cook University Hospital Middlesbrough and clinical professor of anesthesia and pain medicine at Exeter and Durham Universities. His interests include the use neuromodulation for the treatment of neuropathic pain particularly Failed Back Surgery Syndrome, which has led me to an interest in medication management with particular reference to opioids He has published more than 60 articles on the subjects of pain relief and cost effectiveness of various pain procedures. He currently is chief investigator of 8 research projects.
I am a pain & anesthesia boarded physician, who is versed in all interventional percutaneous procedures and implantable pain technologies (SCS, IDDS). Academic and clinic interests include the management of cancer pain, treatment of medically intractable primary headache (interventional), use of implantable neuromodulation devices (SCS, IDDS, other), and the application of regenerative medicine technologies for pain indications.
Dr. Dean S. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2011. Dr. Elterman completed a two-year fellowship in voiding dysfunction, neuro-urology, female urology, and pelvic reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital and Weill Cornell Medical College in New York City. Dr. Elterman’s clinical and research interests include female voiding dysfunction including sacral neuromodulation for overactive bladder, urinary and fecal incontinence, male health, voiding dysfunction, and reconstruction including BPH, incontinence (male sling/artificial urinary sphincter), sexual dysfunction (penile prosthetic surgery). He completed his Master's degree in clinical epidemiology and health services research at Weill Cornell Graduate School of Medical Sciences. He is the medical director of the Prostate Cancer Rehabilitation Clinic at Princess Margaret Hospital Cancer Centre.
Dr. Englot is assistant professor of neurological surgery, radiology, electrical engineering, and biomedical engineering at Vanderbilt University. He is also surgical director of epilepsy at the Vanderbilt University Medical Center. Dr. Englot leads the Brain Imaging and Electrophysiology Network (BIEN) lab at Vanderbilt, which studies brain network dysfunction in epilepsy and other neurological disorders using human neuroimaging and electrophysiology techniques.
Dr. Falowski is a board certified functional neurosurgeon, secretary of the North American Neuromodulation Society, the board-executive of the Congress Neurological Surgeons/American Association Neurological Surgeons pain committee, and executive officer of the American Society Pain and Neuroscience board.
Dr. Faro has been an academic neuroradiologist for the past 25 years. He is most recently from Johns Hopkins University where he was a professor of radiology in the division of neuroradiology. At Johns Hopkins, he was a mentor to younger faculty and was focused on the clinical translation of functional neuroimaging techniques as a tool for characterizing brain and spine pathology. Prior to that, Dr. Faro was a professor of radiology, biomedical, electrical, and computer science engineering at both Drexel and Temple University. Dr. Faro began his academic career at Drexel University where he was director of radiology of the Medical College of Pennsylvania and the MR physics laboratory. He then joined the faculty at Temple University where he was vice chair of radiology research, director of neuroradiology, and director and founder of the MR Physics laboratory and MR Core. The Temple University MRI Core facilitated more than 10 RO1 awards.
Dr. Faro’s primary research focus is in the clinical translational of MR neuroimaging of BOLD and DTI. His research laboratories have trained medical students, residents, and fellows in these MR techniques and trained MS and PhD students from biomedical, electrical, and computer science engineering to become MR physicists. Dr. Faro has an international reputation as an expert neuroradiologist and pioneer in clinical functional neuroradiology. He was a founder and past president of the American Society of Functional Neuroradiology (ASFNR). Dr. Faro maintains an active role in both the ASFNR and the American Society of Neuroradiology (ASNR). He was chair of the ASFNR CPT committee that was instrumental in proposing and directing a 3 year long CPT approval process for 3 new national CPT codes which allow all U.S. centers perform and get reimbursed for clinical fMRI. For these societies, he developed and continues to run a yearly, highly regarded, clinical workshop on the acquisition, data processing and interpretation of clinical BOLD fMRI. This workshop draws MDs and PhDs from all over the world. He is on the editorial board and a reviewer for many prestigious scientific journals. Dr. Faro has been a PI or co-investigator in 18 research grants and has produced 350 peer-reviewed articles, abstracts and book chapters. He has 4 textbooks including a comprehensive text entitled, “Functional Neuroradiology: Principles and clinical applications” that is considered a gold std. text in this field by the American Journal of Neuroradiology and will soon be in its second edition.Dr. Faro is currently professor of radiology and director of functional neuroradiology at Thomas Jefferson University.
Lee Fisher, PhD, is an assistant professor in the department of physical medicine and rehabilitation. He completed his doctoral studies in biomedical engineering at Case Western Reserve University in 2012. His PhD work focused on the use of multi-contact stimulating electrodes to restore standing function after spinal cord injury. Dr. Fisher’s research interests involve the development of neuroprostheses to restore sensory and motor function after neural damage or disease, as well as exploration of the role of somatosensation in maintaining balance control during standing.
Robert S. Fisher, MD PhD, is Maslah Saul MD Professor and Director of the Stanford Epilepsy Center and EEG lab. He had research funding or awards from the Klingenstein Foundation, Epilepsy Foundation, CURE, American Society of Clinical Neurophysiology, NIH, and NSF. He has published about 230 peer-reviewed articles and 3 books. He has been named one of the Best Doctors in America every year from 1996 to 2019. He received the Ambassador Award from the International League Against Epilepsy, the 2005 American Epilepsy Society Service Award, and the 2006 Annual Clinical Research Award. Dr. Fisher is past-president of the American Epilepsy Society, and has served on the board of the International League Against Epilepsy and as editor-in-chief of the journal, Epilepsia. He is past editor-in-chief of the world’s most visited website about epilepsy, epilepsy.com. Dr. Fisher led the projects to develop a formal definition of who has epilepsy and an update of seizure type classification. His recent research is on new devices to detect and treat seizures. He led the clinical trials on deep brain stimulation for epilepsy and on the next-generation (heart-rate-sensing) vagus nerve stimulation device. Dr. Fisher has additionally won several teaching awards and cares for epilepsy patients in the Stanford Epilepsy Clinics and inpatient epilepsy unit.
Michael Fishman, MD, is a board-certified interventional pain management physician with a comprehensive practice including neuromodulation, ablative techniques, and interventions targeting a myriad of painful conditions. Dr. Fishman is actively involved in clinical research, serving as principal investigator on a number of studies. His NANS responsibilities include serving on the board of directors, as co-director of Preconference Workshops, and on various committees.
Dr. Robert D. Foreman, PhD, is George Lynn Cross Research Professor Emeritus in the department of physiology at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma. He has published more than 200 articles in highly regarded, peer-reviewed journals, and was supported by the National Institutes of Health throughout his career. Dr. Foreman is past president of the North American Neuromodulation Society and past president of the North American Neuromodulation Society Foundation. He is section editor of Basic Science for Neuromodulation: Technology at the Neural Interface Journal. He is also acting editor-In-chief of Neuromodulation: Technology at the Neural Interface.
Dr. Halena Gazelka attended medical school at the University of Minnesota, then completed an anesthesiology residency and both pain and palliative medicine fellowships at the Mayo clinic in Rochester, MN. She practices medical and interventional pain management, serving as the director of Mayo clinic inpatient acute and chronic pain services. She devotes a significant portion of her practice to palliative medicine and serves as one of the medical directors of the Mayo Hospice in Rochester. Dr. Gazelka chairs the Mayo Clinic Opioid Stewardship Program, dedicated to improving patient care and reducing opioid diversion and addiction. Further, Dr. Gazelka serves on the Mayo Ethics Subcommittee, teaches in the medical school and serves on the multiple committees with national pain organizations. She is an appointee to and member of the U.S. Health and Human Services Pain Management Task Force by Alex Azar, Secretary, HHS.
Dr. Christopher A. Gilmore, a magna cum laude graduate of Morehouse College in Atlanta, GA, received his medical degree from the University of Tennessee College of Medicine in Memphis. He then completed a residency in anesthesiology at the University of Tennessee Medical Center at Knoxville, obtaining Board Certification in Anesthesiology in April of 2006. He followed that with a Pain Medicine Fellowship at Wake Forest University Baptist Medical Center, gaining subspecialty certification in Pain Medicine in 2007.Dr. Gilmore is a partner at the Carolinas Pain Institute in Winston-Salem and serves as a Clinical Adjunct Faculty at Wake Forest University Baptist Medical Center. He actively participates in the training of anesthesia residents and fellows and is well versed in medication management, interventional techniques, spinal cord and peripheral nerve stimulation, and intrathecal drug delivery.
Christy Gomez is an advanced practice nurse at the University of Illinois at Chicago. She specializes in neurosurgery with a focus on functional neurosurgery. Christy has over 12 years of experience in this field and participates in the care and management of patients with a variety of neurological conditions including pain, movement disorders, epilepsy, and brain tumors. Her areas of interest include surgical treatment of pain and movement disorders.
Board certified in anesthesiology and pain medicine, Dr. Johnathan Goree received his Bachelor of Arts in biology from Washington University in St. Louis. He then moved to New York City where he completed both his medical degree and a residency in anesthesiology at the Weill College of Medicine at Cornell University. Following his time in Manhattan, he completed a fellowship in chronic pain medicine at Emory University Hospital in Atlanta, Georgia. In 2014, Dr. Goree returned home to Little Rock, Arkansas to join the faculty at University of Arkansas for Medical Sciences where he serves as the director of the chronic pain division, director of opioid stewardship, and an assistant professor in the department of anesthesiology. His specific research interests include complex regional pain syndrome, neuromodulation, and the effects of opioid education initiatives on patient outcomes.
Dr. Green has been a consultant (attending surgeon) for 10 years and have implanted over 1000 neuromodulation devices including DBS, DRG, SCS, ONS, and PNS. He regularly teaches DRG and SCS implantation on fellowship and other courses. His main research interest is in control of the autonomic nervous system and pain, including the development of bioelectronic devices to control blood pressure and bladder function.